Lawrence P. Guiheen - Sep 9, 2024 Form 4 Insider Report for ADMA BIOLOGICS, INC. (ADMA)

Role
Director
Signature
/s/ Lawrence P. Guiheen, by Adam S. Grossman as Attorney-in-fact
Stock symbol
ADMA
Transactions as of
Sep 9, 2024
Transactions value $
-$166,189
Form type
4
Date filed
9/11/2024, 09:00 PM
Previous filing
Feb 28, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADMA Common Stock Options Exercise $97.2K +9K +5.85% $10.80 163K Sep 9, 2024 Direct
transaction ADMA Common Stock Sale -$166K -9K -5.52% $18.47 154K Sep 9, 2024 Direct F1, F2
holding ADMA Common Stock 1K Sep 9, 2024 See footnote F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADMA Common Stock Options Exercise -$97.2K -9K -100% $10.80 0 Sep 9, 2024 Common Stock 9K $10.80 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $18.465 to $18.47. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F2 Includes, as of the transaction date, (i) 12,020 restricted stock units granted on February 26, 2024, which will vest fully on February 26, 2025, subject to the Reporting Person's continued service as of such vesting date; and (ii) 141,921 shares of common stock owned by the Reporting Person.
F3 These shares are owned by the Guiheen Trust, of which the Reporting Person serves as a joint trustee.
F4 These options were granted on January 30, 2015 and vested in twenty-four equal monthly installments, becoming fully vested on January 30, 2017.
F5 The Reporting Person is exercising these options due, in part, to their near-term expiration date.

Remarks:

Exhibit 24 - Power of Attorney